Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 7, 2005; 11(5): 665-671
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.665
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.665
Table 9 Chromosome aberrations in mice after bicyclol treatment.
| Dosage (mg/kg) | -S9 | +S9 | ||||
| Aberration (%) | P | Aberration (%) | P | |||
| Control (DMSO) | 100 | 2 | 100 | 3 | ||
| Bicyclol 50 | 100 | 2 | 100 | 2 | >0.05 | |
| >0.05 | ||||||
| 100 | 100 | 3 | >0.05 | 100 | 3 | >0.05 |
| 200 | 100 | 2 | >0.05 | 100 | 3 | >0.05 |
| Carboplatin 100 | 50 | 84 | <0.001 | |||
| CY 100 | ||||||
| 50 | 66 | <0.001 | ||||
- Citation: Liu GT, Li Y, Wei HL, Lu H, Zhang H, Gao YG, Wang LZ. Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study. World J Gastroenterol 2005; 11(5): 665-671
- URL: https://www.wjgnet.com/1007-9327/full/v11/i5/665.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i5.665